NASDAQ:SAGE   Sage Therapeutics, Inc.
Big volume, end of the day Sep 17 shows that nstitutionals are buying.
There is a reason: SAGE receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
Technically looks strong: cap and handle pattern is bullish

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.